Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

OBJECTIVE: The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mov Disord
Auteurs principaux: Takeshige‐Amano, Haruka, Saiki, Shinji, Fujimaki, Motoki, Ueno, Shin‐Ichi, Li, Yuanzhe, Hatano, Taku, Ishikawa, Kei‐Ichi, Oji, Yutaka, Mori, Akio, Okuzumi, Ayami, Tsunemi, Taiji, Daida, Kensuke, Ishiguro, Yuta, Imamichi, Yoko, Nanmo, Hisayoshi, Nojiri, Shuko, Funayama, Manabu, Hattori, Nobutaka
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2020
Sujets:
Regular Issue Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496239/
https://ncbi.nlm.nih.gov/pubmed/32357260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28068
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires